A detailed history of Nwk Group, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Nwk Group, Inc. holds 10,903 shares of VRTX stock, worth $4.92 Million. This represents 2.09% of its overall portfolio holdings.

Number of Shares
10,903
Previous 10,987 0.76%
Holding current value
$4.92 Million
Previous $5.15 Million 1.53%
% of portfolio
2.09%
Previous 2.16%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$460.0 - $505.78 $38,640 - $42,485
-84 Reduced 0.76%
10,903 $5.07 Million
Q1 2024

May 10, 2024

BUY
$407.69 - $446.08 $4.48 Million - $4.9 Million
10,987 New
10,987 $4.59 Million
Q1 2021

May 14, 2021

SELL
$207.02 - $241.31 $1,863 - $2,171
-9 Closed
0 $0
Q4 2020

Feb 10, 2021

SELL
$207.01 - $276.09 $2.32 Million - $3.1 Million
-11,231 Reduced 99.92%
9 $2,000
Q3 2020

Nov 16, 2020

BUY
$255.65 - $303.1 $69,281 - $82,140
271 Added 2.47%
11,240 $3.06 Million
Q2 2020

Aug 13, 2020

BUY
$225.48 - $295.8 $75,535 - $99,093
335 Added 3.15%
10,969 $3.18 Million
Q1 2020

May 12, 2020

BUY
$199.77 - $247.81 $2.12 Million - $2.64 Million
10,634 New
10,634 $2.53 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Nwk Group, Inc. Portfolio

Follow Nwk Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwk Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nwk Group, Inc. with notifications on news.